Kim D. Blickenstaff - 25 May 2022 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ Rachel Malina, Attorney-in-Fact for Kim D. Blickenstaff
Issuer symbol
TNDM
Transactions as of
25 May 2022
Net transactions value
$0
Form type
4
Filing time
27 May 2022, 21:43:53 UTC
Previous filing
19 May 2022
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNDM Common Stock 10,657 25 May 2022 Direct
holding TNDM Common Stock 205,190 25 May 2022 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Award $0 +2,757 $0.000000 2,757 25 May 2022 Common Stock 2,757 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
F2 Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F3 Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F4 RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.